World Health Organization. Cardiovascular diseases Fact sheet reviewed September 2016. http://www.who.int/mediacentre/factsheets/fs317/en/.
Kraus S, Ogunbanjo G, Sliwa K, Ntusi NAB. Heart failure in sub-Saharan Africa: A clinical approach. S Afr Med J 2016;106(1):23-31.
Ntusi NB, Mayosi BM. Epidemiology of heart failure in sub-Saharan Africa. Expert Rev Cardiovasc Ther. 2009 Feb;7(2):169-80.
Makubi A, Hage C, Lwakatare J, et al. Contemporary aetiology, clinical characteristics and prognosis of adults with heart failure observed in a tertiary hospital in Tanzania: the prospective Tanzania Heart Failure (TaHeF) study. Heart. 2014 Aug; 100(16): 1235-41.
Pallangyo P, Fredrick F, Bhalia S, et al. Cardiorenal Anemia Syndrome and Survival among Heart Failure Patients in Tanzania: A Prospective Cohort Study. BMC Cardiovasc Disord. 2017; 17:59.
Parmar KR, Xiu PY, Chowdhury MR, et al. In-hospital treatment and outcomes of heart failure in specialist and non-specialist services: a retrospective cohort study in the elderly Open Heart 2015; 2:e000095.
Karaye KM, Sani MU. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study. BMC Cardiovasc Disord. 2008; 8: 16.
Gheorghiade M, Patel K, Filippatos G, et al. Effect of oral digoxin in high-risk heart failure patients: a pre-specified subgroup analysis of the DIG trial. Eur J Heart Fail. 2013 May; 15(5): 551–59.
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med. 2011; 364(1):11-21.
Metra M, Teerlink JR, Voors AA, et al. Vasodilators in the treatment of acute heart failure: what we know, what we don't. Heart Fail Rev. 2009; 14:299–307.
Konstam MA, Rousseau MF, Kronenberg MW, Udelson JE, Melin J, Stewart D, et al. Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators. Circulation. 1992; 86(2):431-8.
Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme. Lancet. 2003; 362(9386):759-66.
Haas SJ, Vos T, Gilbert RE, Krum H. Are beta-blockers as efficacious in patients with diabetes mellitus as in patients without diabetes mellitus who have chronic heart failure? A meta-analysis of large-scale clinical trials. Am Heart J. 2003; 146:848–53.
Yusuf S, Islam S, Chow CK et al., Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey. The Lancet 2011; 378 (9798): 1231–43.
Simpson SH, Eurich DT, Majumdar SR, et al. A metaanalysis of the association between adherence to drug therapy and mortality. BMJ. 1006; 333:18 –26.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005; 353:487– 497.
Ho PM, Bryson CL, Rumsfeld JS. Medication Adherence: Its Importance in Cardiovascular Outcomes. Circulation. 2009; 119:3028-3035.
Oosterom-Calo R, van Ballegooijen AJ, Terwee CB, et al. Determinants of adherence to heart failure medication: a systematic literature review. Heart Fail Rev 2013; 18:409–427.
Juarez DT, Williams AE, Chen C, et al. Factors Affecting Medication Adherence Trajectories for Patients With Heart Failure. Am J Manag Care. 2015; 21(3):197-205.
Molloy GJ, O’Carroll RE, Witham MD, et al. Interventions to Enhance Adherence to Medications in Patients With Heart Failure: A Systematic Review. Circ Heart Fail. 2012; 5:126-133.
Fitzgerald AA, Powers JD, Ho PM, et al. Impact of medication nonadherence on hospitalizations and mortality in heart failure. J Card Fail. 2011;17(8):664–669.
Shah D, Simms K, Barksdale DJ, Wu JR. Improving medication adherence of patients with chronic heart failure: challenges and solutions. Research Reports in Clinical Cardiology 2015:6 87–95.
Ruppar TM, Delgado JM, Temple J. Medication adherence interventions for heart failure patients: A meta-analysis. Eur J Cardiovasc Nurs. 2015 Oct; 14(5):395-404.
Ruppar TM, Cooper PS, Mehr DR, et al. Medication Adherence Interventions Improve Heart Failure Mortality and Readmission Rates: Systematic Review and Meta-Analysis of Controlled Trials. J Am Heart Assoc. 2016 June; 5(6).
Toh CT, Jackson B, Gascard DJ, et al. Barriers to Medication Adherence in Chronic Heart Failure Patients during Home Visits. J Pharm Pract Res 2010; 40: 27-30.
Sabate´ E. Adherence to long-term therapies: evidence for action. World Health Organization, Geneva, Switzerland, 2003.
Kemp C, Conte J. The pathophysiology of heart failure. Cardiovasc Pathol. 2012; 21(5):365–371.
O’Connor CM, Stough WG, Gallup DS, Hasselblad V, Gheorghiade M. Demographics, clinical characteristics, and outcomes of patients hospital¬ized for decompensated heart failure: observations from the IMPACT-HF registry. J Card Fail. 2005;11(3):200–205.
Aggarwal B, Pender A, Mosca L, Mochari-Greenberger H. Factors associated with medication adherence among heart failure patients and their caregivers. J Nurs Educ Pract. 2015; 5(3):22-27.
Zhang Y, Wu SH, Fendrick AM, Baicker K. Variation in Medication Adherence in Heart Failure. JAMA Intern Med. 2013;173(6):468-470.
Knafl GJ, Riegel B. What puts heart failure patients at risk for poor medication adherence? Patient Prefer Adherence. 2014 Jul 17;8:1007-18.
Dickson VV, Knafl GJ, Riegel B. Predictors of Medication Nonadherence Differ Among Black and White Patients with Heart Failure. Res Nurs Health. 2015 Aug; 38(4): 289–300.
Wu JR, Frazier SK, Rayens MK, et al. Medication Adherence, Social Support, and Event-Free Survival in Patients with Heart Failure. Health Psychol. 2013 Jun; 32(6): 637–646.
Alakhali KM, Daniel PS, Noohu AM, Sirajudeen SA. Patient Medication Adherence and Physician Prescribing among Congestive Heart Failure Patients of Yemen. Indian J Pharm Sci. 2013 Sep-Oct; 75(5): 557–562.
Lee D, Mansi I, Bhushan S, Parish R. Non-Adherence in At-Risk Heart Failure Patients: Characteristics and Outcomes. Journal of Nature and Science, 2015; 1(5):e95
Mujtaba SF, Masood T, Saad M. Reasons of Medical Noncompliance in Heart Failure Patients. Pakistan Heart Journal. 2010 July-Dec; 43 (3-4)
Dunlay SM, Eveleth JM, Shah ND, et al. Medication Adherence Among Community-Dwelling Patients With Heart Failure. Mayo Clin Proc. 2011 Apr; 86(4): 273–281.
Albert NM. Improving medication adherence in chronic cardiovascular disease. Crit Care Nurse. 2008 Oct;28(5):54-64; quiz 65.
Leventhal MJ, Riegel B, Carlson B, De GS. Negotiating compliance in heart failure: remaining issues and questions. Eur J Cardiovasc Nurs. 2005; 4:298-307.
Antonicelli R, Testarmata P, Spazzafumo L, et al. Impact of telemonitoring at home on the management of elderly patients with congestive heart failure. J Telemed Telecare. 2008; 14:300–305.
Antonicelli R, Mazzanti I, Abbatecola AM, Parati G. Impact of home patient telemonitoring on use of b-blockers in congestive heart failure. Drugs Aging. 2010;27:801–805.
Assyag P, Renaud T, Cohen-Solal A, et al. RESICARD: East Paris network for the management of heart failure: absence of effect on mortality and rehospitalization in patients with severe heart failure admitted following severe decompensation. Arch Cardiovasc Dis. 2009;102:29–41.
Bisharat B, Hafi L, Baron-Epel O, et al. Pharmacist counselling to cardiac patients in Israel prior to discharge from hospital contribute to increasing patient’s medication adherence closing gaps and improving outcomes. J Transl Med. 2012; 10:34.
Bocchi EA, Cruz F, Guimaraes G, et al. Long-term prospective, randomized, controlled study using repetitive education at six-month intervals and monitoring for adherence in heart failure outpatients: the REMADHE trial. Circ Heart Fail. 2008;1:115–124.
DeWalt DA, Schillinger D, Ruo B, et al. Multisite randomized trial of a single-session versus multisession literacy sensitive self-care intervention for patients with heart failure. Clin Trial Regist. 2012;125:2854–2862.
Falces C, Lopez-Cabezas C, Andrea R, et al. Intervencion educativa para mejorar el cumplimiento del tratamiento y prevenir reingresos en pacientes de edad avanzada con insuficiencia cardıaca [An educative intervention to improve treatment compliance and to prevent readmissions of elderly patients with heart failure]. Med Clin (Barc). 2008;131:452–456.
Ferrante D, Varini S, Macchia A, et al; on behalf of the GESICA Investigators. Long-term results after a telephone intervention in chronic heart failure: DIAL (randomized trial of phone intervention in chronic heart failure) follow-up. J Am Coll Cardiol. 2010;56:372–378.
Powell LH, Calvin JE Jr, Richardson D, et al. Self-management counselling in patients with heart failure: the heart failure adherence and retention randomized behavioral trial. JAMA. 2010;304:1331–1338.
Shively MJ, Gardetto NJ, Kodiath MF, et al. Effect of patient activation on self-management in patients with heart failure. J Cardiovasc Nurs. 2013;28:20–34.
Unverzagt S, Meyer G, Mittmann S, et al. Improving Treatment Adherence in Heart Failure: A Systematic Review and Meta-analysis of Pharmacological and Lifestyle Interventions. Dtsch Arztebl Int. 2016 Jun; 113(25): 423–430.